Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma
- PMID: 20731025
- PMCID: PMC2928465
- DOI: 10.3748/wjg.v16.i32.4089
Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma
Abstract
Aim: To study the expression profiles of MUC2 and MUC5AC in tumorigenesis of colorectal carcinoma and in its different pathologic types.
Methods: Formalin-fixed, paraffin-embedded human colorectal tissue specimens were immunostained with antibodies against MUC2 and MUC5AC. Six samples of normal mucosa (NM), 12 samples of hyperplastic polyp (HP), 15 samples of tubular adenoma with low-grade dysplasia (LGD), 14 samples of tubular adenoma with high-grade dysplasia (HGD), 26 samples of conventional colorectal adenocarcinoma (CCA), 15 samples of mucinous carcinoma (MC), and 8 samples of signet-ring cell carcinoma (SRCC) were collected.
Results: MUC2 was the most widely expressed protein in each study group, although the number of MUC2-positive cases was less in CCA group than in other groups (P < 0.05). The staining score for MUC2 was significantly decreased in the HP-LGD-HGD-CCA sequence (r = -0.73436, P < 0.0001). Among the neoplasms, MC and SRCC were more frequently associated with the high expression of MUC2 (P < 0.05) than with that of CCA. MUC5AC expression was detected in all groups but not in NM group. Furthermore, the staining score for MUC5AC was higher in HP, LGD, HGD, MC and SRCC groups than in NM and CCA groups (P < 0.05). The frequency of simultaneous expression of MUC proteins was significantly higher in MC and SRCC groups than in CCA group (P < 0.05).
Conclusion: Alterations in MUC expression occur during colorectal tumorigenesis. The transformation process in MC and SRCC may be different from that in the traditional adenoma-carcinoma sequence.
Figures


Similar articles
-
An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.Int J Clin Exp Pathol. 2013;6(4):613-21. Epub 2013 Mar 15. Int J Clin Exp Pathol. 2013. PMID: 23573307 Free PMC article.
-
Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.World J Gastroenterol. 2013 Jul 7;19(25):3957-68. doi: 10.3748/wjg.v19.i25.3957. World J Gastroenterol. 2013. PMID: 23840140 Free PMC article.
-
Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.Int J Oncol. 2005 Oct;27(4):957-64. Int J Oncol. 2005. PMID: 16142311
-
Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature.Indian J Gastroenterol. 2015 Jan;34(1):63-7. doi: 10.1007/s12664-015-0534-y. Epub 2015 Mar 4. Indian J Gastroenterol. 2015. PMID: 25731647 Review.
-
Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.Acta Chir Belg. 2013 Nov-Dec;113(6):385-90. Acta Chir Belg. 2013. PMID: 24494463 Review.
Cited by
-
Differential expression of mucins in Middle Eastern patients with colorectal cancer.Oncol Lett. 2016 Jul;12(1):393-400. doi: 10.3892/ol.2016.4672. Epub 2016 Jun 1. Oncol Lett. 2016. PMID: 27347157 Free PMC article.
-
An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.Int J Clin Exp Pathol. 2013;6(4):630-8. Epub 2013 Mar 15. Int J Clin Exp Pathol. 2013. PMID: 23573309 Free PMC article.
-
Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance.Stem Cell Res. 2018 Mar;27:109-120. doi: 10.1016/j.scr.2018.01.016. Epub 2018 Jan 28. Stem Cell Res. 2018. PMID: 29414601 Free PMC article.
-
MUC1 and MUC5AC implication in Tunisian colorectal cancer patients.Turk J Med Sci. 2021 Feb 26;51(1):309-318. doi: 10.3906/sag-2003-29. Turk J Med Sci. 2021. PMID: 32967412 Free PMC article.
-
Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.Cancer Lett. 2016 May 1;374(2):304-14. doi: 10.1016/j.canlet.2016.02.016. Epub 2016 Feb 16. Cancer Lett. 2016. PMID: 26898938 Free PMC article.
References
-
- Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta. 2006;1765:189–222. - PubMed
-
- Itoh Y, Kamata-Sakurai M, Denda-Nagai K, Nagai S, Tsuiji M, Ishii-Schrade K, Okada K, Goto A, Fukayama M, Irimura T. Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin. Glycobiology. 2008;18:74–83. - PubMed
-
- Kanoh A, Takeuchi H, Kato K, Waki M, Usami K, Irimura T. Interleukin-4 induces specific pp-GalNAc-T expression and alterations in mucin O-glycosylation in colonic epithelial cells. Biochim Biophys Acta. 2008;1780:577–584. - PubMed
-
- Komatsu K, Jono H, Lim JH, Imasato A, Xu H, Kai H, Yan C, Li JD. Glucocorticoids inhibit nontypeable Haemophilus influenzae-induced MUC5AC mucin expression via MAPK phosphatase-1-dependent inhibition of p38 MAPK. Biochem Biophys Res Commun. 2008;377:763–768. - PubMed
-
- Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004;23:77–99. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous